Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, November 7, 2023
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
Matthew Harrison Maintained (ZNTL) at Buy with Decreased Target to $38 on, Nov 7th, 2023
Matthew Harrison of Morgan Stanley, Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Buy with Decreased Target from $55 to $38 on, Nov 7th, 2023.
Matthew has made no other calls on ZNTL in the last 4 months.
There are 2 other peers that have a rating on ZNTL. Out of the 2 peers that are also analyzing ZNTL, 0 agree with Matthew's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Matthew
- Derek Archila of "Wells Fargo" Maintained at Buy with Decreased Target to $50 on, Thursday, August 10th, 2023
- Robert Driscoll of "Wedbush" Reiterated at Buy and Held Target at $38 on, Thursday, August 10th, 2023
